Fig. 4From: Metabolomic alterations associated with Behçet’s diseaseSerum level of arachidonic acid (AA) and linoleic acid (LA) in the validation cohort. Levels of AA (a) and LA (b) in patients with Behçet’s disease (BD) (n = 25), systemic lupus erythematosus (SLE) (n = 12), rheumatoid arthritis (RA) (n = 12), Takayasu’s arteritis (TA) (n = 15), and Crohn’s disease (CD) (n = 15), and healthy controls (HC) (n = 19). Statistical significance between disease groups and HC was determined using a two-tailed student t test. *p < 0.05, **p < 0.01, ***p < 0.001. n.s. not significantBack to article page